Medtronic receives FDA approval for glucose monitoring system

Source: Healthcare Digital

Date :29/01/2008 05:43:24

Medtronic, the U.S. medical device maker, said on Tuesday it has been granted FDA approval for CGMS iPro Recorder, a physician-use continuous glucose monitoring system.

The GMS iPro is used to identify how everyday activities can affect patients' diabetes management. Patients wear the the iPro recorder for three days, after which physicians can review the data and use the results to uncover glucose patterns and optimize patient therapy, the company said.

CGM technology

“CGMS iPro is the latest step in Medtronic’s CGM technology revolution,” said Chris O’Connell, president of the Diabetes business at Medtronic. “CGMS iPro represents a major breakthrough in making CGM a more central element of physician practice.”

According to the American Diabetes Association, almost 21 million Americans (seven percent) have the disease, which affects children and adults.

January 29, 2008